Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mDCs: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo.
Introduction
Recent studies have investigated hypoxia effects on DC differentiation, maturation, and functions. We reported that monocyte differentiation into iDCs under chronic hypoxia promotes the onset of a unique migratory phenotype by differentially modulating the expression profile of chemokines/receptors and genes involved in cell adhesion and tissue remodeling 12,13. Other studies indicated that acute iDC exposure to low pO2 may either impair 14 or promote 5, 15 their maturation, by affecting expression of chemokine receptors, costimulatory molecules, and T cell priming ability. However, the impact of chronic hypoxia on mDC development and functional behaviour in inflammatory states is still largely unknown.
In this study, we demonstrate that the gene expression pattern of mDCs generated from human monocytes under chronic hypoxia (H-mDCs) is distinct from that of mDCs developing under normal O2 levels and characterized by upregulation of genes coding for surface costimulatory and adhesion molecules, immunoregulatory and pattern recognition receptors (PRRs). Among them, we identify the triggering receptor expressed on myeloid cells (TREM)-1, a member of the Ig superfamily of immunoreceptors and a strong amplifier of the immune responses 16,17, as a new hypoxia-inducible gene in mDCs. We provide evidence that this receptor is biologically active and expressed in vivo on mDCs recruited to the hypoxic joints of Juvenile Idiopatic Arthritis (JIA) patients, pointing to a pathogenetic role for this molecule in the disease.
Methods

DC generation and culture
Blood monocytes were isolated from healthy volunteers at a purity of >93%, plated into sixwell culture plates (BD-Falcon) in RPMI 1640 (Euroclone) supplemented with 10% heatinactivated FCS (HyClone), and incubated for 4 days under normoxic (20% O2) or hypoxic (1% O2) conditions in the presence of GM-CSF and IL-4 (both 100 ng/ml), as detailed 12,13. A cocktail of proinflammatory mediators containing TNF(50 ng/ml), IL-1β(50 ng/ml), IL-6 (10 ng/ml), and PGE 2 (1mM) was added for the last 48hr to induce DC maturation. Hypoxic conditions were obtained by culturing cells in an anaerobic work-station incubator (CARLI Biotec) flushed with a mixture of 1% O2, 5% CO2, and 94% N2.
Medium was allowed to equilibrate in the hypoxic incubator for 2hr before use, and pO2 was monitored using a portable oxygen analyzer (Oxi 315i/set, WTW).
Synovial fluid mononuclear cell isolation
Synovial fluid (SF) samples were obtained at the time of therapeutic knee arthrocentesis from eight children affected by oligoarticular JIA 18 and collected into sodium-heparin tubes under vacuum. pO2 levels in SF samples were monitored to confirm hypoxic conditions. Paired PB samples and PB from five age-matched control subjects undergoing venepuncture for minor orthopedic procedures were obtained on the occasion of routine venepuncture and collected as for SF. Informed consent was obtained according to the procedure approved by the Gaslini's Ethical Committee. Specimens were centrifuged to prepare cell-free SF and plasma and separated by Ficoll to isolate mononuclear cells (SFMCs and PBMCs). SF-derived samples were handled in the anaerobic incubator to prevent cell reoxygenation, as detailed 19,20. 
Cytokines and antibodies
Human recombinant GM-CSF, IL-4, TNFα, IL-1β, and IL-6 were from PeproTech; PGE 2 was from Sigma. mAbs used for FACS: anti-CD83-FITC or PE-Cy5 and anti-CD86-FITC (BD-Pharmingen), anti-TREM-1-PE, anti-CXCR4-FITC, and anti-CCR7-FITC (R&D Systems), anti-CD1a-FITC or -APC (Serotec), anti-CD1-FITC and anti-CD141-APC (Miltenyi-Biotec). Proper isotype-matched control Abs (Dako) were used.
Abs used for western blot: mouse anti-human TREM-1 (R&D Systems), mouse anti-human HIF-1α(BD-Biosciences), rabbit anti-human phospho (p)-ERK)-1, p-Akt, and p-IkBα(Cell Signaling Technology), mouse anti-human DAP12, rabbit anti-human ERK-1, Akt, IkBαand β-actin (SantaCruz Biotechnology),
Flow cytometry
Flow cytometry was performed as described12, 13 . Cells resuspended with PBS supplemented with 0.2% BSA, 0.01% NaN3 were incubated with fluorochrome-conjugated mAbs for 30 min at 4°C, after blocking nonspecific sites with rabbit IgG (Sigma). Fluorescence was quantitated on a FACSCalibur flow cytometer equipped with CellQuest software (BD-Biosciences). Cells were gated according to their light-scatter properties to exclude cell debris.
RNA isolation and GeneChip hybridization
Total RNA was purified from different donor-derived mDCs using the Qiagen RNeasy MiniKit and reverse-transcribed into double-stranded cDNA on a GeneAmp PCR System 2700 thermal cycler (Applied Biosystems) using the one-cycle cDNA synthesis kit (Affymetrix). cDNA derived from three donors was purified and biotin labeled with the IVT-expressed kit (Affymetrix), as described21.
Fragmented cRNA was hybridized to Affymetrix HG-U133 plus 2.0 arrays (Genopolis Corporation) containing 54,000 probe sets coding for 38,500 genes, chips were stained with streptavidinphycoerythrin (Invitrogen) and scanned using an Affymetrix GeneChip Scanner 3000, as described 21. Data capturing was conducted with standard Affymetrix analysis software algorithms (Microarray Suite 5.0). Comparative analysis of hypoxic relative to normoxic expression profiles was carried out with GeneSpring Expression Analysis Software Gx9.0 (Silicon Genetics), and expression data were normalized using "per chip normalization" and "per gene normalization" algorithms. Fold-change was calculated as the ratio between the average expression level under hypoxia and normoxia. We selected a modulated gene list of two-fold induction/inhibition with a false discovery rate of 0%. The significance of gene expression differences between the two experimental conditions was calculated using the Mann-Whitney U-test. Only genes that passed the test at a confidence level of 95% (P<0.05) were considered significant. Complete data set for each microarray experiment was lodged in the Gene Expression Omnibus public repository at NCBI (www.ncbi.nlm.nih.gov/geo/) [accession Nr.GSE22282]. Gene Ontology (GO) data mining for biological process at level 1 was conducted online using the Database for Annotation, Visualization and Integrated Discovery (DAVID) software (http://david.niaid.nih.gov).
HRE consensus elements consisting of a 4nt core (CGTG) flanked by degenerated sequences ((T|G|C)(A|G)(CGTG)(C|G|A)(G|C|T)(G|T|C)(C|T|G)) were mapped in the promoter regions of genes represented in the chip, as detailed 12.
Real-time RT-PCR
Real time PCR (qRT-PCR) was performed on a 7500 Real Time PCR System (Applied), using SYBRGreen PCR Master Mix and sense/antisense oligonucleotide primers (TIBMolbiol) (listed in Table S1 ). Expression data were normalized on the values obtained in parallel for three reference genes (indicated in Table S1) selected among those not affected by hypoxia in the Affymetrix analysis using the Bestkeeper software, and relative expression values were calculated using Q-gene software, as detailed 21.
Cross-linking of TREM-1-positive cells
12-well flat-bottom tissue culture plates (Costar) precoated with 10µg/ml of agonist anti-TREM-1 mAb or control IgG1 were incubated ON at 37°C before seeding 8x10 5 H-mDCs/well/ml of RPMI 1640 w/o cytokines. Plates were briefly spun at 1200 rpm to engage TREM-1. After 24hr stimulation under hypoxia, supernatants were harvested and tested for cytokine/chemokine content by ELISA. In a set of experiments, cells were plated in medium w/o FCS, plates centrifuged and incubated for 20 min at 37oC under hypoxic conditions. ERK1, Akt and IBαphosphorylation was then assessed by western blot.
Western blot analysis and immunoprecipitation
Total protein extracts were prepared as described 13, subjected to SDS-PAGE, transferred to PVDF membranes (Millipore), and probed with specified Abs. In a few experiments, lysates were subjected to immunoprecipitation with 10µg/ml anti-TREM-1 mAb or control IgG1 ON at 4°C, and protein G-Sepharose 4B (GE-Healthcare) for 45 min at 4°C. Precipitates were separated by SDSPAGE and immunoblotted with anti-DAP12 mAb. Chemiluminescence detection was carried out with peroxidaseconjugated goat anti-rabbit and anti-mouse Abs using an ECL kit (Pierce).
ELISA
Conditioned medium (CM) was replaced on day 3 or 4 of mDCs generation with fresh medium supplemented with cytokines for 24hr, and tested for soluble (s)TREM-1 content by ELISA (R&D Systems) after additional 24hr culture. sTREM-1 was also quantified in SF and plasma samples. TNFα, IL-6, IL-12p70, IL-10, IL-8, CCL4, and CCL5 were measured in CM from mDCs triggered with anti-TREM-1 mAb or control mAb by specific ELISA (R&D Systems). Data were analyzed with the GraphPad Prism-5 Software.
Statistical analysis
Data are the mean ±SE of three independent experiments, unless differently specified. The Student's ttest was used to determine results'significance (p<0.05). sTREM-1 concentrations in SF and plasma specimens were evaluated by the Wilcoxon rank test (p<0.05 statistically significant).
Results
Gene expression profile of hypoxic mDCs
mDCs were generated by culturing human monocytes under normoxic and hypoxic conditions in the presence of GM-CSF/IL-4 for 4 days and a cocktail of pro-inflammatory stimuli for the last 48hr. As determined by flow cytometry (Fig.1) , both mDCs and H-mDCs displayed the mature phenotype, characterized by high surface expression of CD1a differentiation marker, CD83 maturation marker, and CCR7 chemokine receptor, undetectable in fresh monocytes, and by upregulation of CD86 costimulatory molecule and CXCR4 chemokine receptor, in agreement with previous observations 13. H-mDC transcriptional profile was then assessed by microarray analysis. Pairwise comparison between data sets from normoxic and hypoxic samples revealed differential modulation of a large number of transcripts. The majority of differentially expressed genes were identified as unique and named in the GenBankTM, whereas the remaining transcripts were either ESTs or hypothetical. After restricting the profile to sequences exhibiting ≥2-fold expression differences, we identified 563 up-and 402 downregulated genes by hypoxia ( Fig.2) , which were selected for further analysis. These results provided the first indication that mDCs and H-mDCs had a different gene expression signature.
To gain insights into the nature of hypoxia-induced changes, selected genes were clustered into various functional categories according to GO data mining. We highlighted 33 interrelated functional pathways, containing a statistically significant portion of hypoxia-modulated genes (Fig.2 ). H-mDC transcriptional profile was mainly associated to cell growth, differentiation, and/or maturation, and angiogenesis regulation. Several upregulated genes fell into pathways implicated in signal transduction, metabolic processes, and apoptosis. Interestingly, a prominent set of upregulated genes had immunological relevance, coding for proteins involved in immune regulation, inflammatory responses, cell migration and adhesion.
Characterization of hypoxia-inducible immune-related genes
Among immune-related genes, profound differences were observed in the expression of a large cluster (63) of cell surface receptor-encoding genes (Table I) . These include several PRRs critical to host defense, such as CD180, various complement receptor components, toll-like receptors (TLRs)-1 and -2, C-type lectin receptors CLEC-2D,-2B,-7A, and macrophage receptor with collagenous structure (MARCO). Of interest is also the upregulation of scavenger receptors implicated in the regulation of fatty acid and/or cholesterol uptake/transport, such as thrombospondin receptor (CD36) and apolipoprotein B48 receptor (APOB48R). A set of genes coding for costimulatory and adhesion/homing molecules was also upregulated, such as several integrin family members, L1 cell adhesion molecule These data suggest that hypoxia can exert a profound modulatory effect on mDC innate and adaptive immune functions.
The possible relationship between gene inducibility by hypoxia and HRE presence in the promoter was then investigated by mapping HRE sequences in the first 2000 bases upstream the transcription initiation site. Interestingly, we found that ≈56% of upregulated genes contained at least one member of the HRE family in the promoter, whereas the others were HRE-( Table I) , indicating that a remarkable portion of the hypoxic transcriptome does not require HIF-1 binding.
To validate microarray results, mRNA levels for a subset of genes selected among those listed in Table I were quantified by qRT-PCR in pooled RNA from mDCs and H-mDCs generated from different donors ( Fig.S1 ). A few known hypoxia target genes were analyzed in parallel as positive controls (indicated in Fig.S1 ). We found a ≈90% concordance between qRT-PCR and Affymetrix data with respect to the direction of the expression changes, although differences in the extent of modulation were observed for some genes. CD85, CD9, and CLEC2B upregulation by hypoxia was not confirmed by qRT-PCR.
TREM-1 is expressed in hypoxic mDCs
Among validated genes, TREM-1 was that displaying the highest expression difference in H-mDCs vs mDCs ( Fig.S1 ). TREM-1 was previously reported to be selectively expressed in blood neutrophils and a subset of blood monocytes and tissue macrophages and to be completely downregulated during monocyte differentiation into DCs 16,17. Hence, we were interested in further investigating TREM-1 regulation and functional significance in H-mDCs.
To address the issue of donor-to-donor variability, we evaluated TREM-1 mRNA expression in H-mDCs generated from five donors by qRT-PCR ( Fig.3A) . Expression of CAXII metalloenzyme was assessed in parallel as an index of response to hypoxia 22. TREM-1 transcript levels were significantly higher in H-mDCs than in mDCs from all tested samples, paralleling those of CAXII, with differences ranging from 23-to 516-fold among individual donors. In keeping with the mRNA data, marked TREM-1 immunoreactivity was observed by Western blot analysis in HmDCs lysates, whereas TREM-1 was almost undetectable in mDCs ( Fig.3B ), suggesting that its expression is restricted to cells generated under hypoxia.
TREM-1 surface expression was then measured by cytofluorimetry. The left panel of Figure 3C (Table S2 ), suggesting a correlation between TREM-1 and CD141 expression. A soluble form of TREM-1 (sTREM-1) was described in biological fluids during inflammation 16,24. We evaluated sTREM-1 content in CM from mDCs and H-mDCs. sTREM-1 was released by H-mDCs but not by mDCs, ranging from 79 to 207 pg/10 6 cells/ml in eight different donors DC exposure to hypoxia was previously shown to be associated with HIF-1αprotein accumulation and target gene induction 13-15. Given the presence of HRE in the gene promoter (Table I) , we investigated the potential involvement of HIF-1αin TREM-1 hypoxic induction by RNA interference. As depicted in Supplemental Figure 2 , high levels of HIF-1αwere present in mDCs cultured for 24hr under hypoxia and were associated with TREM-1 expression. HIF-1α silencing decreased TREM-1 protein levels, whereas it did not modify the expression of βactin used as an internal control. These data suggest that TREM-1 inducibility by hypoxia in mDCs is mediated at least in part by HIF-1α
TREM-1 cross-linking on H-mDCs promotes DAP12-signaling activation and proinflammatory cytokine and chemokine release
TREM-1 is a transmembrane receptor which lacks signaling motifs in the short cytoplasmic tail and non-covalently associates with the adapter molecole, DAP12, for signal transduction in human monocytes and neutrophils 17,24,25. To confirm TREM-1 association with DAP12, 4-day HmDCs were subjected to immunoprecipitation with anti TREM-1 mAb, and the precipitates were analyzed by anti-DAP12 immunoblotting. As shown in Figure 6A , TREM-1 paired with DAP12, consistent with a role for this protein in mediating TREM-1 signaling in H-mDCs. To determine whether TREM-1 was functionally competent, H-mDCs were plated on a plastic surface coated with an agonist mAb or control IgG for 20 min under hypoxia, and activation of DAP12-signaling pathway was assessed. TREM-1 cross-linking resulted in increased phosphorylation of DAP12-linked molecules, ERK-1, Akt, and IBα, indicating that TREM-1 engagement can transduce activating signals in H-mDCs ( Fig.6B ).
TREM-1 is an amplifier of the inflammatory response 17,24. Hence, we investigated whether its activation triggered proinflammatory cytokine and chemokine production by H-mDCs.
Supernatants from H-mDCs were collected 24hr after stimulation with agonist anti-TREM-1 or control IgG1 under hypoxic conditions and analyzed for cytokine and chemokine content by ELISA ( Fig.6C ). TREM-1 cross-linking significantly enhanced TNF-α, IL-6, IL-12p70, CXCL8, CCL4, and CCL5 secretion compared to Ig, whereas production of the anti-inflammatory cytokine IL-10 was not affected.
No changes in cytokine secretion were observed upon triggering with an isotype matched anti-MHC-I mAb (data not shown), confirming that H-mDC activation by anti-TREM-1 mAb was not due to aspecific Fc receptor ligation. Overall, these data suggest that TREM-1 is a functional receptor selectively expressed by H-mDCs and not by the normoxic counterpart whose engagement can drive production of cytokines and chemokines involved in innate and adaptive immunity, raising the question of the existence of TREM-1+ mDCs in vivo.
TREM-1 is expressed in vivo on H-mDCs recruited to the synovial fluid of JIA patients
TREM-1 has been recently implicated in the pathogenesis of non-infectious inflammatory disorders, including rheumatoid arthritis (RA) 26,27. Hypoxia is a common feature of the inflamed rheumatoid synovium 8,28, and evidences suggest that DCs are enriched in arthritic joints playing a role in the initiation and perpetuation of the inflammatory process 23,29. To evaluate TREM-1+ mDCs occurrence in vivo, we investigated whether TREM-1 was expressed in synovial mDCs from children affected by JIA.
We first analyzed plasma and SF samples obtained from JIA patients for sTREM-1 content by ELISA.
As shown in Figure 7A , plasma sTREM concentrations in JIA patients (61-394 pg/ml) were significantly higher (P <0.01) than those in control subjects (12-16pg/ml) and were further increased (P value<0,001) in matched SF samples (1120-3800 pg/ml).
These data are in line with previous observations in other forms of inflammatory arthritis, such as RA 26,27, indicating disease activity.
SFMCs were then isolated from a subset of patients and analyzed for TREM-1 surface expression. HIF-1αprotein was also evaluated in parallel by western blotting to confirm cell adaptation to the hypoxic synovial environment. SFMCs, but not paired PBMCs, constitutively accumulated high levels of HIF-1α( Fig 7B) , confirming recent observations 19,20. The presence of TREM-1+ mDCs in SFMCs was then determined by three-color flow cytometric analysis with mAbs to CD1a, CD83, and TREM-1. As shown in Figure 7C , a subset of SFMCs, ranging from 4.6%-to 6.6% in three different patients, expressed CD1a (left panels), confirming DC enrichment in JIA SF. A high proportion of DCs in JIA SF expressed CD83 ( Fig.7C , right panels), comprising 42, 25, and 20% of the total CD1a-gated cells in patient 1, 3, and 6, respectively (upper + lower right quadrants). Noteworthily, 88, 60, and 80% of cells within the CD83+ subset expressed TREM-1, accounting for 37, 15, and 16% of the total CD1a-gated population (upper right quadrants). These findings provide the first evidence of the existence in a human hypoxic tissue in vivo of a population of CD83+ mDCs expressing TREM-1, correspondent to mDCs generated in vitro under low pO2, suggesting the potential relevance of this molecule as an in vivo marker of hypoxic mDCs.
Discussion
mDC development from monocytic precursors recruited at sites of inflammation and infection occurs in the setting of low pO2 5,6. The impact of the hypoxic microenvironment on DC maturation process is still controversial. This study characterizes the transcriptional profile of mDCs generated from human monocytes under chronic hypoxic conditions similar to those present in diseased tissues, demonstrating that H-mDCs are functionally reprogrammed through the differential expression of a large number of genes involved in innate and adaptive immunity. Clustering of hypoxia-modulated genes according to GO data mining identified 33 interrelated functional categories, containing a statistically significant portion of genes controlling cell metabolism, differentiation/maturation, and functional properties. Interestingly, a large cluster of genes belonging to immune-related pathways was upregulated in H-mDCs respect to mDCs.
These findings extend to mDCs the characteristic trend of response to hypoxia of other types of mononuclear phagocytes, including primary monocytes, monocyte-derived macrophages and iDCs 12,21,33, emphasizing the critical contribution of reduced oxygenation to the control of immune responses. mDCs are critical for the induction of protective immunity to microbial invasion and the maintenance of self-tolerance 34. Their functions are tightly regulated by a complex network of inhibitory and activating signals transduced by a defined repertoire of cell surface receptors 4,24,35,36, and dysregulated expression of these molecules may result in an aberrant response characterized by amplification of inflammation and loss of tolerance 2,4,34. DC maturation under chronic hypoxia resulted in the upregulation of genes encoding various members of these receptor families. Profound changes were observed in genes coding for PRRs critical to host defense, which are endowed with the capability to recognize specific PAMPs on infectious agents and trigger proinflammatory cytokine production 36-38, suggesting enhanced inflammatory functions of mDCs generated in hypoxic than in normoxic areas. Upregulation of mRNA for the scavenger receptors, CD36 and APOB48R, is also of note and consistent with the view that hypoxia may exert a pathogenetic role in atherosclerosis7, because these molecules function as endocytic transporters for lipoproteins and phospholipids, contributing to lipid-loaded foam cell formation 39,40. mDC migration is known to be highly sensitive to microenvironmental changes 2-4. We observed higher expression of mRNA for several adhesion/homing receptors and costimulatory molecules in H-mDCs compared to mDCs. Given the role of the encoded proteins in cell-cell and cellmatrix interactions, transendothelial migration and trafficking, and T cell costimulatory activity 41,42, it is likely that H-mDCs have an increased capacity to migrate to secondary lymphoid organs and activate adaptive immune responses than the normoxic counterparts.
Hypoxia also affected the expression pattern of genes coding for immunoregulatory Ig-like receptor family members involved in the regulation of myeloid cell functions in innate and adaptive immunity.
Of relevance, is the increased mRNA for Ig-Fc receptors. These are activating receptors characterized by "immunoreceptor tyrosine-based activating motifs" (ITAM) in their cytoplasmic domain (FcγRIIC, FcαR, FcεRI) or pairing with an ITAM-containing transmembrane adaptor proteins for signaling (FcγRIIIA), which trigger phagocytosis and immune complex clearance, inflammatory cytokine production, ADCC, and respiratory burst 43. Hypoxic upregulation of other genes encoding Ig family members, such as BDCA3, LILRA2, and SEMA4D 35,44,45, was also observed. These molecules modulate DC maturation, immunogenicity, cooperation with T cells, and pro-inflammatory cytokine production. Our results suggest that hypoxia can affect mDC functional behaviour in diseased tissues and potentially contribute to the pathogenesis of allergic inflammatory disorders and/or autoimmune diseases, which are associated with overexpression of these receptors 44-46. The challenge of future studies will be to validate these data in vivo.
An intriguing finding of this study is the identification of TREM-1 as a hypoxia-inducible gene in mDCs. Previous reports have shown that TREM-1 is selectively expressed on neutrophils and on a subset of monocytes and tissue macrophages, where it can be markedly upregulated by various stimuli, such as TLR ligands and proinflammatory cytokines, whereas it is completely down-regulated during monocyte differentiation/maturation into DCs 16,17,24,25. Our results provide the first evidence that TREM-1 can be expressed in mDCs generated under chronic hypoxia.
TREM-1 mRNA was consistently detected in H-mDCs from different donors and paralleled by expression of the membrane-bound receptor and release of its soluble form. Interestingly, TREM-1mRNA and protein expression was also inducible upon mDC exposure to acute hypoxia, although at levels lower than those induced by chronic hypoxia, and was reversible, because cell reoxygenation resulted in TREM-1 downregulation. Consistent with these findings, HIF/HRE system appeared to be involved at least in part in TREM-1 hypoxic induction. These results suggest that TREM-1 expression in mDCs in vivo may vary dynamically with the degree of local oxygenation, which is quite heterogeneous and rapidly fluctuating in diseased tissues9, giving rise to distinct mDC subsets potentially endowed with different functional properties.
TREM-1 expressed on H-mDC paired with DAP12 adapter protein and was biologically active, because its engagement resulted in the activation of DAP12-linked signaling, as shown by increased ERK-1 and Akt kinase phosphorylation. These data are in agreement with previous observations in primary monocytes and neutrophils 17,24,25. TREM-1 cross-linking on H-mDCs triggered secretion of TNFα, IL-6, CXCL8, CCL4, and CCL5, which are important proinflammatory and chemotactic factors 4,13,21,29, and of IL-12p70, a Th1-inducing cytokines essential for adaptive immune responses against intracellular pathogens and tumors 4,34. These data support and extend previous findings implicating TREM-1 as an amplifier of inflammation 17, 24 and suggest that the hypoxic environment enhances mDC ability to regulate leukocyte recruitment at inflammatory sites and Th1 priming by stimulating TREM-1 expression. Increased nuclear levels of NF-kBα were observed in response to TREM-1 cross-linking in monocytes and neutrophils 25 Increased TREM-1 expression and sTREM-1 release were observed in several infectious and noninfectious inflammatory disorders, suggesting a pathogenetic role for this molecule 16,17,24,26,27,48. Our data add to the growing list of diseases associated with TREM-1 overexpression, providing the first evidence of elevated sTREM-1 levels in JIA. JIA is the most common chronic pediatric rheumatic disease18, and sTREM-1 presence in JIA-SF is an index of the underlying inflammatory process whose persistence and amplification is dictated by the functional cooperation among several inflammatory cell populations recruited to the synovium of affected joints 28, including TREM-1+ monocytes/macrophages and neutrophils 26,27,48. We have recently documented the presence of reduced pO2 in the JIA synovium and the contribution of the hypoxic environment to the persistence of inflammation by triggering leukocyte recruitment and activation 19,20,28. The demonstration that SFMCs express HIF-1αconfirms the adaptation of synovial inflammatory cells to local hypoxia. Previous studies have demonstrated accumulation of both DC precursors and myeloid DC subsets in the SF and ST from children affected by JIA 23,28. Consistent with these findings, our immunophenotypical data demonstrated enrichment of cells expressing the DC marker CD1a in JIA synovial effusions, which comprised up to 6.6% of the total SFMC population. Although CD1a+ DCs had a predominantly immature phenotype (CD83-), a high percentage of mature (CD83+) DCs was also present in hypoxic JIA-SF, and the majority of cells in the CD83+ subset expressed TREM-1. Taken together with in vitro findings, the demonstration of TREM-1 expression in vivo on mDCs present in hypoxic JIA-SF strongly suggest the potential relevance of this molecule as a marker of mDCs generated under hypoxic conditions. Furthermore, the observation that also the majority of cells belonging to the CD83-subset in JIASF was TREM-1+, indicates that TREM-1 expression is independent of the DC maturation stage, representing a common in vivo marker of hypoxic DCs. Sustained TREM-1 induction on synovial DCs by intraarticular hypoxia may be of pathological relevance, representing a potential mechanism of amplification of synovial inflammation, and future studies will be aimed at assessing the role of TREM-1 putative ligand(s) 49 
BE870509
MET (HGFR)* met proto-oncogene (hepatocyte growth factor receptor) Proto-oncogene encoding the trosine-kinase receptor for hepatocyte growth factor and scatter factor; expressed in a variety of organs and cell types; plays a role in cell growth and motility in many physiologic and pathologic processes 3.4 AF280547 NRP1* neuropilin 1 Membrane-bound coreceptor to tyrosine kinase receptors for vascular endothelial growth factor, class 3 semaphorins, and placenta growth factor; involved in the control of cell growth and migration; plays a role in angiogenesis and axon guidance; mediates contacts between DCs and T cells and is essential for the initiation of the primary immune response (PAMPs) expressed on infectious agents and mediates the production of cytokines necessary for the activation of innate immunity NM_003264 TLR2* toll-like receptor 2 Member of the Toll-like receptor (TLR) family; expressed on cells of the innate immune system, plays an essential role in the innate immune recognition of pathogen-associated molecular patterns (PAMPs) expressed on infectious agents leading to the generation of an immune response; implicated in the pathogenesis of several auto-immune and inflamatory diseases 7.7
NM_018643
TREM-1* triggering receptor expressed on myeloid cells 1 Ig superfamily immunoregulatory receptor expressed on monocytes/macrophages and neutrophils; stimulates their proinflammatory functions and acts as an inflamatory amplifier priming cells to respond to other stimuli via functional interaction with TLRs; regulation of integrin function via Plexin-A1.; involved in inflammatory diseases and septic shock.
39.8
1557444_at TREML3 triggering receptor expressed on myeloid cells-like 3 Ig superfamily immunoregulatory receptor expressed on myeloid cells, structurally related to the TREM genes and located in the TREM gene cluster on human chromosome 6 5.9
^Gene expression profiling was carried out independently on the RNA purified from three independent N-and H-mDC preparations, and comparative analysis of gene expression diferences between the two experimental conditions was conducted as described in the Materials and Methods. Each gene is given a representative GeneBank accession number, a common gene symbol, a brief gene description, and the fold increase value. Underlined genes were validated by qRT-PCR. §The indicated values are calculated as the ratio of hypoxic/normoxic signals (mean of expression level of three experiments). Genes increased by ≥2 fold are shown.
*Genes whose promoter contain members of the HRE family 
